Skip to main content
Table of Contents
Print

Are there any long-term risks of using cannabis for migraine treatment? 

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

While cannabis can provide relief for migraine  sufferers, it is important to consider the long-term cannabis risks for migraines. Research suggests that regular, prolonged use may lead to tolerance, reduced effectiveness, and potential health impacts over time. 

The discussion around cannabis chronic use for migraine risks is growing, as more people turn to this natural treatment. Although many patients tolerate cannabis well, certain long-term effects should be monitored to ensure migraine cannabis safety long-term. 

Possible Long-Term Health Concerns 

Understanding potential issues can help you make informed decisions about your treatment. 

Development of Tolerance 

Over time, your body may require higher doses to achieve the same relief, increasing consumption. 

Cognitive Function Changes 

Long-term cannabis use may affect memory, focus, and learning ability in some individuals. 

Respiratory Issues 

Smoking cannabis regularly could lead to breathing problems, particularly for sensitive users. 

Mental Health Effects 

Some people may experience mood changes, anxiety, or depression with prolonged use. 

Medication Interaction Risks 

Cannabis may interact with other medications used for migraine prevention or pain relief. 

In summary, while cannabis can be effective for migraine relief, being aware of the long-term cannabis risks for migraines ensures safer use. By understanding cannabis for migraine health concerns and staying alert to any changes in your health, you can work with your healthcare provider to create a balanced, sustainable treatment plan. 

If you’re exploring cannabis treatment options for migraines, visit providers like LeafEase for personalised consultations and guidance tailored to your needs. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and migraines. 

Julia Sutton, MSc
Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Dr. Clarissa Morton, PharmD
Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy. 

Categories